RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 1-11
  • News of the Weird: Norway's Battle Against Chaos

    News of the Weird: Norway's Battle Against Chaos
    Norwegian public television (NRK), which introduced the now-legendary continuous, live log-burning show (12 hours long, with “color commentary” on the historical and cultural importance of fire), scheduled a new program for this week in its...
  • Seasonal Allergies

    Seasonal Allergies
    It just might be the only unwelcome sign of spring: Seasonal Allergies. The sniffling, sneezing and burning eyes are back. "The pollen count is higher than normal this year, mainly because of the prolonged cold we had in the winter", says FOXCT...
  • Childhood Vaccinations

    Childhood Vaccinations
    The decision to vaccinate your children: a parents choice or public health risk? Last week, reality TV star Kristin Cavallari talked about about how she and her husband weren't vaccinating their children because she said, "I've read too many books about...
  • Raising Awareness About Morning Sickness Medication

    Raising Awareness About Morning Sickness Medication
    Reports of Kate Middleton's severe morning sickness opened eyes about how hard pregnancy can be for some women.  "I went to the emergency room because I was so sick and dehydrated after a week of not being able to eat or drink," says Megan Donofrio of...
  • Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant

    BOSTON (Reuters) - Billionaire investor William Ackman, whose fund is the largest shareholder in Allergan Inc., and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer David Pyott tried to discredit Valeant as it was making a hostile...
  • AbbVie CEO Gonzales loses Shire, but wins praise for gutsy move

    NEW YORK (Reuters) - AbbVie Chief Executive Officer Richard Gonzalez for three months led the charge to buy Dublin drugmaker Shire for $55 billion, only to walk away from the deal last week, but analysts and fund managers said he deserves credit for...
  • Valeant says may raise Allergan bid; beats on profit

    (Reuters) - Valeant Pharmaceuticals International Inc VRX.TO VRX.N said on Monday that it may raise its bid for Botox maker Allergan Inc AGN.N after the Canadian company posted a better-than-expected quarterly profit. Valeant CEO Michael Pearson said a...
  • Top Allergan holder Paulson urges deal with Shire: sources

    Top Allergan holder Paulson urges deal with Shire: sources
    (Reuters) - Allergan Inc shareholder Paulson & Co is urging the Botox maker to merge with specialty pharmaceutical company Shire Plc as an alternative to a deal with hostile bidder Valeant Pharmaceuticals International Inc , according to two people...
  • Ebola scams spreading as fears mount

    Ebola scams spreading as fears mount
    I can't tell you whether to believe assurances from those in power that the deadly Ebola virus will be kept in check, but there's no doubt that panicking can expose you to harm. Scams related to the Ebola outbreak are spreading and you aren't immune....
  • AbbVie says tax rule changes scuttled deal for Shire

     AbbVie says tax rule changes scuttled deal for Shire
    AbbVie is blaming the Obama administration for pulling the plug on its $55 billion proposed acquisition of Irish drugmaker Shire, asserting that the largest corporate deal of the year no longer made economic sense under new federal tax regulations. Late...
  • Durbin hopes tide turning against corporate inversions

    WASHINGTON Senate Majority Whip Richard J. Durbin, D-Ill., is hoping the tide is turning against corporate inversions a practice aimed at minimizing U.S. taxes by merging with overseas firms. After taking to the Senate floor to shame Chicago-based...